HIF1A and pneumonia: Consequently, we hypothesized that HIF-1α stabilization in MSCs would enhance their therapeutic efficacy in experimental lung injury and pneumonia, potentially by improving cell survival in the face of inflammatory, cytotoxic stimuli.